40th week of 2012 patent applcation highlights part 47 |
Patent application number | Title | Published |
20120251392 | Biosensor Using Magnetic Microparticles - Provided is a biosensor using magnetic microparticles whereby a biomaterial can be detected at a high sensitivity. The biosensor using magnetic microparticles is provided with a light source ( | 2012-10-04 |
20120251393 | DISPENSING NOZZLE FOR AUTOMATIC ANALYZER, AND AUTOMATIC ANALYZER INCLUDING SAME - An automatic analyzer for analyzing samples, such as urine and blood, is adapted so that analysis measured values are not affected by carry over by a repeatedly used dispensing nozzle. Coating the surface of the dispensing nozzle with a chemisorbed polyethylene glycol derivative forms a molecular layer that inhibits the adsorption of biopolymers, to reduce carry over by the dispensing nozzle. | 2012-10-04 |
20120251394 | CHEMICAL HEAT ACCUMULATOR - A chemical heat accumulator includes a receptacle, a first reaction vessel, and a second reaction vessel. The first reaction vessel is hermetically connected to the receptacle and supplied with water from the receptacle. The first reaction vessel contains a chemical compound that causes a hydration reaction with the water from the receptacle to generate water vapor by a heat of reaction, and causes a dehydration reaction by receiving heat. The second reaction vessel is hermetically connected to the first reaction vessel and supplied with the water vapor from the first reaction vessel. The second reaction vessel contains a chemical heat storage material that generates heat by causing a hydration reaction with the water vapor from the first reaction vessel and stores heat through a dehydration reaction caused by receiving heat. The chemical heat storage material is thermally in contact with an object to be heated. | 2012-10-04 |
20120251395 | OZONE GAS SUPPLY SYSTEM - An ozone gas output flow rate management unit configured to receive a plurality of ozone gas outputs from a plurality of ozone generation units and capable of performing an ozone gas output flow rate control for selectively outputting one or a combination of two or more of the plurality of ozone gas outputs to any of a plurality of ozone treatment apparatuses by performing an opening/closing operation of a plurality of ozone gas control valves provided in the ozone gas output flow rate management unit. | 2012-10-04 |
20120251396 | DEVICE FOR SORTING CARBON NANOTUBES - A method for sorting carbon nanotubes (CNTs) is disclosed. In one embodiment, a method for sorting CNTs of the present disclosure comprises providing to a surface of a substrate, the surface modified with a trans isomer of photo-isomerization-reactive diazo compound, a dispersion containing a mixture of conducting CNTs and semiconducting CNTs; removing CNTs which are not associated with the modified surface from the surface; and irradiating the modified surface to detach the CNTs associated with the modified surface. | 2012-10-04 |
20120251397 | ODOR CONTROL SYSTEM AND METHOD - The present invention relates to odor control systems and more particularly to a system and method for treating air to remove odors and return the treated air to the atmosphere. In one embodiment, an odor control system includes an ionization assembly, which has several ionizers producing an ionized air flow. The system also includes a foul air intake providing a foul air flow, such as from a wastewater treatment or other processing plant. The system also includes a reaction chamber, which provides a reaction volume for reaction of the foul air flow and the ionized air flow. The ionized air reacts with constituents in the foul air to treat the foul air for release of treated air to the environment. | 2012-10-04 |
20120251398 | HONEYCOMB FILTER - A honeycomb filter | 2012-10-04 |
20120251399 | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO) - A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal. | 2012-10-04 |
20120251400 | HONEYCOMB STRUCTURAL BODY AND EXHAUST GAS CONVERSION APPARATUS - A honeycomb structural body includes at least one honeycomb unit including a β type zeolite, a phosphate group zeolite, and an inorganic binder and having a plurality of through holes divided by partition walls and arranged in a longitudinal direction of the honeycomb unit. The β type zeolite includes secondary particles having an average particle diameter of approximately 0.5 μm or more and approximately 5 μm or less. The phosphate group zeolite includes primary particles having an average particle diameter of approximately 0.5 μm or more and approximately 5 μm or less. A ratio of a mass of the phosphate group zeolite with respect to a total mass of the β type zeolite and the phosphate group zeolite is approximately 5% or more and approximately 35% or less. | 2012-10-04 |
20120251401 | HONEYCOMB STRUCTURE, METHOD OF MANUFACTURING HONEYCOMB STRUCTURE, AND EXHAUST GAS CONVERTER - A honeycomb structure includes a honeycomb unit having a plurality of through holes defined by partition walls along a longitudinal direction of the honeycomb unit. The honeycomb unit is manufactured by molding raw material paste by extrusion molding and thereafter by firing the molded raw material paste. The raw material paste contains zeolite obtained by ion-exchange with iron ions and an inorganic binder. A specific surface area of the zeolite is more than or equal to approximately 500 m | 2012-10-04 |
20120251402 | HONEYCOMB STRUCTURE AND EXHAUST GAS PURIFYING APPARATUS - A honeycomb structure includes a ceramic block including a plurality of honeycomb fired bodies. Each of the plurality of honeycomb fired bodies includes large volume cells and small volume cells. Either one of the end portions of each of the large volume cells and the small volume cells is plugged. An aperture in the cross section in a central part of the honeycomb structure is about 65% or more. A ratio of an aperture of the first end face to an aperture of the second end face of the honeycomb structure is about 1.4 or more. Each of the cell walls except the peripheral walls has a thickness of about 0.1 mm to about 0.2 mm. The honeycomb structure has a diameter of about 200 mm or more. A ratio of a length to the diameter of the honeycomb structure is about 1.0 or less. | 2012-10-04 |
20120251403 | APPARATUS FOR PRODUCING DIESEL - An apparatus is disclosed for hydrocracking hydrocarbon feed in a hydrocracking unit and hydrotreating a diesel product from the hydrocracking unit in a hydrotreating unit. The hydrocracking unit and the hydrotreating unit shares the same recycle gas compressor. A warm separator separates recycle gas and hydrocarbons from diesel in the hydrotreating effluent, so fraction of the diesel is relatively simple. The warm separator also keeps the diesel product separate from the more sulfurous diesel in the hydrocracking effluent, and still retains heat needed for fractionation of lighter components from the low sulfur diesel product. | 2012-10-04 |
20120251404 | PURIFYING CARBON DIOXIDE USING ACTIVATED CARBON - Carbon dioxide-containing feed stream such as flue gas is treated to produce a high-purity carbon dioxide stream by a series of steps including removing SOx and NOx with activated carbon, carrying out subambient-temperature processing to produce a product stream and a vent stream, and treating the vent stream by pressure swing adsorption or by physical or chemical absorption to produce a product stream which is recycled to the feed stream. | 2012-10-04 |
20120251405 | Dispensing contact lens cleaning liquid - The eyes of a contact lens wearer are protected from the effects of a liquid disinfecting solution by providing a contact lens container having a catalyst therein and a container of the disinfecting solution of unusual design. The openings of the contact lens container and the solution container are configured so only the contact lens container is able to receive solution from the solution container. This prevents the user from directly removing disinfecting solution from the solution container and thereby prevents the user from directly applying the disinfecting solution to the eye. | 2012-10-04 |
20120251406 | Process for Isomerizing a Non-Equilibrium Alkylaromatic Feed Mixture and an Aromatic Production Facility - One exemplary embodiment can be a process for the isomerization of a non-equilibrium alkylaromatic feed mixture. The process can include contacting the non-equilibrium alkylaromatic feed mixture in a C8 isomerization zone. The C8 isomerization zone may include a first isomerization stage and a second isomerization stage. At the first isomerization stage, at least a portion of the non-equilibrium alkylaromatic feed mixture can be contacted at a first isomerization condition in a liquid phase in the substantial absence of hydrogen to obtain an intermediate stream. At the second isomerization stage, at least part of the intermediate stream and at least a part of a stream rich in at least one naphthene can be contacted at a second isomerization condition to obtain a concentration of at least one alkylaromatic isomer that is higher than a concentration of that at least one alkylaromatic isomer in the non-equilibrium alkylaromatic feed mixture. | 2012-10-04 |
20120251407 | FURNACE COIL FINS - The present invention provides low profile, thick (“stubby”) longitudinal fins having a cross section which is a parallelogram, trapezoid or a triangle extending from 10% to 100% of a coil pass and comprising from 3 to 45 weight % of a coil in a radiant section of a furnace for thermally cracking one or more of paraffins and naphtha. The fins provide an additional surface through which heat may be transferred to the coil making the coil more efficient reducing greenhouse emissions. | 2012-10-04 |
20120251408 | PROCESS TO PROVIDE A PARTICULATE SOLID MATERIAL TO A PRESSURISED REACTOR - A system to provide a particulate solid material to a pressurised gasification reactor includes a low pressure storage vessel fluidly connected to the inlet of a bulk materials pump, a first part of a transport conduit directly connecting the outlet of the bulk materials pump to an inlet of a diverter valve, a second part of the transport conduit connecting an outlet of the diverter valve to a burner as present in a reactor vessel, wherein said diverter valve is provided with a second outlet connecting a recycle conduit with the low pressure storage vessel and which diverter valve is adjustable to either fluidly connect the bulk materials pump to the burner or alternatively fluidly connect the bulk materials pump to the low pressure storage vessel. | 2012-10-04 |
20120251409 | TEST STRIP CONSTRUCTION - A test strip construction includes a test strip having a testing region bearing a chromogenic reagent to detect the presence of a substance in a fluid test sample. A supporting member is attached to one end of the test strip in a manner such that the testing region is remote form the attachment point and is free from any contact with supporting member. When dipped into the test sample the test strip can flutter away from the supporting member to allow for full contact between that the testing region and the test sample. When removed from the test sample the supporting member provides a consistent background for observation of color changes of the reagent. | 2012-10-04 |
20120251410 | FLUIDIC CHIP WITH LAMINATED REINFORCING LAYER FOR PRESSURE REINFORCEMENT - A fluidic chip device configured for processing a fluidic sample includes two outer boundary layers, and at least one reinforcing layer arranged between the two outer boundary layers and being at both of its opposing main surfaces laminated with directly adjacent layers to reinforce pressure resistance of the fluidic chip device by the lamination, in which at least a part of the layers of the fluidic chip device includes a hole forming at least a part of a fluidic conduit for conducting the fluidic sample under pressure. | 2012-10-04 |
20120251411 | CENTRIFUGE TUBE - The present invention relates to a centrifuge tube for use in the centrifugation of biological materials, wherein the diameter of the centrifuge tube is improved to enable minute centrifugation, and in which a thin, weak, and narrow portion of the centrifuge tube, to which a strong force is to be applied, is provided with a support piece to enable centrifugation to be performed without causing a deformation in the centrifuge tube. The centrifuge tube of the present invention enables the centrifugation of materials using differences in the specific gravities of the materials to be easily performed without using a reagent or the like. The centrifuge tube of the present invention has a closure made of a material such as a rubber, polyethylene, polypropylene, silicon or the like, such that a needle may penetrate through the closure and the centrifuge tube can be protected from contamination caused by bacteria, and centrifugation of biological materials can be performed in a closed space. | 2012-10-04 |
20120251412 | FILTRATION APPARATUS - A filtration apparatus includes: a filtration chamber; a sample introducing port for introducing a sample into the filtration chamber; a sample discharge port disposed at a position on an opposite side of the filtration chamber from the sample introducing port; a filtration filter provided in the filtration chamber to filter the sample introduced from the sample introducing port; and a filtrate discharge port for discharging filtrate which has passed through the filtration filter. The filtration filter is disposed such that its filter face is parallel to a flowing direction of the sample introduced from the sample introducing port when the sample discharge port is open. An opening and closing mechanism for opening and closing the sample discharge port is disposed between the filtration chamber and the sample discharge port. | 2012-10-04 |
20120251413 | FILTER VIAL - A filter vial and piston are provided where the vial has a cylindrical wall with a closed bottom and open top and with the hollow, tubular piston therein. The piston has a distal end covered by a cup having a proximal cup seal extending outward to engage the walls of the vial to form a fluid tight seal with the vial during use. The distal end of the piston has a piston flange extending outwardly and located adjacent a recess in the piston so the cup forms a snap fit over the piston flange and extends into the recess. The piston flange causes the cup to bulge sufficiently outward to form a fluid tight seal with the vial during use. A filter is placed in the bottom of the cup and abuts an inwardly extending lip on the cup. The filter is held against the lip by a piston support at the distal end of the piston. A cup support at a distal end of the cup also helps support the filter. | 2012-10-04 |
20120251414 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 2012-10-04 |
20120251415 | METHOD FOR THE PURIFICATION OF RADIUM FROM DIFFERENT SOURCES - The invention is directed to a method for the purification of Radium, in particular | 2012-10-04 |
20120251416 | PROCESS FOR RECYCLING OF TUNGSTEN CARBIDE ALLOY - The present disclosure is a process for the recycling of tungsten carbide alloy. Tungsten carbide alloy scrap is heated in an oxidizing atmosphere and the oxidized material is pulverized by grinding. The powder material is treated with a carburizing mixture for reducing and carburizing the powdered tungsten oxides and other metal oxides. The method is cost effective and environment friendly. | 2012-10-04 |
20120251417 | Method for Recovering Metal, and Reagent and Kit for Recovery of Metal for Use in the Same - A method for recovering a metal, capable of recovering a metal easily without requiring the use of an organic medium, is provided. A complex between a chelating agent and a metal present in a sample is formed in a mixture prepared by mixing the chelating agent and the sample under pH conditions where the chelating agent can be insoluble in an aqueous medium. Then, the complex is recovered from the mixture, and further, the metal is recovered by dissolving the recovered complex in an aqueous medium under pH conditions that are different from the pH conditions where the chelating agent can be insoluble in an aqueous medium. By this method, a metal can be recovered easily without requiring the use of the use of an organic medium. | 2012-10-04 |
20120251418 | RETENTION OF AMINES IN THE REMOVAL OF ACID GASES BY MEANS OF AMINE ABSORPTION MEDIA - A method for removing acid gases from a fluid stream comprises a) treating the fluid stream in an absorption zone with an absorption medium which comprises an aqueous solution of at least one amine, conducting the treated fluid stream through at least two scrubbing zones and treating it with a non-acidic aqueous phase in order to transfer entrained amine and/or entrained amine decomposition products at least in part to the aqueous phase, wherein aqueous phase is recycled via at least one scrubbing zone and aqueous phase is conducted through at least one scrubbing zone without recycling. The method permits efficient retention of amines from the treated fluid streams. | 2012-10-04 |
20120251419 | EXHAUST GAS CONVERSION SYSTEM AND EXHAUST GAS CONVERSION METHOD - An exhaust gas conversion system includes an oxide catalyst, a filter, a selective catalytic reduction catalyst and an ammonia supplying device. The filter has a honeycomb structural body including a honeycomb unit. The selective catalytic reduction catalyst has a honeycomb structural body including a honeycomb unit. The oxide catalyst, the filter and the selective catalytic reduction catalyst are sequentially arranged in a direction in which an exhaust gas flows. A ratio of an area of a cross section of the selective catalytic reduction catalyst perpendicular to a longitudinal direction of the selective catalytic reduction catalyst with respect to an area of a cross section of the filter perpendicular to a longitudinal direction of the filter is approximately 0.55 or more and approximately 0.90 or less. The area of the cross section of the filter is approximately 300 cm | 2012-10-04 |
20120251420 | REMOVAL OF CO<sb>2</sb> FROM GASES HAVING LOW CO<sb>2</sb> PARTIAL PRESSURES, USING 2,2'-(ETHYLENEDIOXY)-BIS-(ETHYLAMINE) (EDEA) - A method of removing acid gases from a fluid flow, using an absorption agent comprising an aqueous solution of 2,2′-(ethylenedioxy)-bis-(ethylamine). | 2012-10-04 |
20120251421 | PROCESSES FOR REDUCING NITROSAMINE FORMATION DURING GAS PURIFICATION IN AMINE BASED LIQUID ABSORPTION SYSTEMS - Acid gas purification processes for reducing nitrosamine precursor formation from a gas stream containing NOx, wherein the acid gas is selectively absorbed in an amine based wash solution comprising at least one secondary diamine. The processes generally include absorbing carbon dioxide from the gas stream containing NOx species with the amine-based wash solution comprising at least one secondary diamine to provide a carbon dioxide lean gas stream that is released into the surroundings, wherein absorbing the acid gas forms a rich amine solution; and regenerating the rich amine solution at an elevated temperature to release the carbon dioxide to form a regenerated lean amine solution, wherein absorbing and regenerating are configured to promote formation of carbamate species of at least one diamine. | 2012-10-04 |
20120251422 | Fe-SAPO-34 CATALYST AND METHODS OF MAKING AND USING THE SAME - There is disclosed a method of making, through direct synthesis, a catalyst comprising an Fe-SAPO-34 molecular sieve. There is also disclosed an Fe-SAPO-34 molecular sieve made according to the disclosed method herein, wherein the molecular sieve contains both framework iron and iron cations at ion-exchange sites. In addition, there is disclosed a method of using the Fe-SAPO-34 disclosed herein in a selective catalytic reduction reaction, typically in the presence of ammonia or urea, to reduce or remove nitric oxides from exhaust emissions. | 2012-10-04 |
20120251423 | Methods For Reducing The Acidic Gas Content of Effluent Gases - Methods for reducing the acidic gas content of effluent gas streams are disclosed. The methods generally involve reducing the acidic gas content of combustion gases passing through a duct by injecting hydrated lime or pulverized quicklime into the duct by use of a shrouded injector which reduces the incidence of occlusion of the injector. | 2012-10-04 |
20120251424 | METHOD FOR THE REMOVAL OF PHOSPHORUS - A process for producing a hydrocarbon from biomass. A feed stream containing biomass having fatty acids, mono-, di-, and/or triglycerides, and a phosphorus content of between about 1 wppm and about 1,000 wppm is provided. A heated hydrocarbon solvent and a hydrogen-rich gas are provided. The feed stream, the heated hydrocarbon solvent, and the hydrogen-rich gas are combined in the presence of a low activity hydrogenation catalyst. A spent low activity hydrogenation catalyst is recovered at the end of a run wherein the spent low activity hydrogenation catalyst contains at least 3% by weight phosphorus. | 2012-10-04 |
20120251425 | CASCADING PURIFICATION - The present invention provides a method of purifying a material using a cascading dissolution and washing process. The dissolution and washing processes can contain single or multiple stages. Water and dissolving chemicals are recycled through the process towards the beginning of the process. | 2012-10-04 |
20120251426 | Polycrystalline Silicon For Solar Cell And Preparation Method Thereof - The present invention provides a process for preparing a polycrystalline silicon having the surface layer in which the areas having a short carrier lifetime due to Fe has been substantially eliminated. A preparation method of polycrystalline silicon comprising preparing a mold evenly applied with a mold release agent produced by mixing a binder and a solvent with a silicon nitride powder and then solidifying a molten silicon in said mold, wherein x≦5.0, 20≦y≦100 and x×y≦100 are satisfied given that x represents a concentration of Fe (atomic ppm) contained as impurity in the silicon nitride powder and y represents a thickness of the mold release agent (μm) applied to the mold. | 2012-10-04 |
20120251427 | REACTOR AND METHOD FOR PRODUCTION OF SILICON - Reactor for production of silicon, comprising a reactor volume, distinctive in that the reactor comprises or is operatively arranged to at least one means for setting a silicon-containing reaction gas for chemical vapor deposition (CVD) into rotation inside the reactor volume. Method for production of silicon. | 2012-10-04 |
20120251428 | CRYSTAL GROWING APPARATUS, METHOD FOR MANUFACTURING NITRIDE COMPOUND SEMICONDUCTOR CRYSTAL, AND NITRIDE COMPOUND SEMICONDUCTOR CRYSTAL - Disclosed is a crystal growing apparatus, which is useful when growing a nitride semiconductor crystal by means of hydride vapor phase deposition, and which is capable of effectively preventing a reaction tube from breaking, and is capable of growing the high quality nitride semiconductor single crystal. Also disclosed are a method for manufacturing the nitride compound semiconductor crystal using such crystal growing apparatus, and the nitride compound semiconductor crystal. In the horizontal-type crystal growing apparatus for growing the nitride compound semiconductor crystal on a base substrate using the hydride vapor phase deposition, between the reaction tube ( | 2012-10-04 |
20120251429 | SYSTEMS AND METHODS OF PRODUCING CHEMICAL COMPOUNDS - Systems and methods of producing chemical compounds are disclosed. An example chemical production system includes an intake chamber having intake ports for entry of a gas mixture. An igniter ignites the gas mixture in the intake chamber. A nozzle restricts exit of the ignited gas mixture from the intake chamber. An expansion chamber cools the ignited gas with a cooling agent. The expansion chamber has an exhaust where the cooled gas exits the expansion chamber. A chemical compound product is formed in the expansion chamber. | 2012-10-04 |
20120251430 | NITROGEN OXIDE AND HYDROCYANIC ACID PRODUCTION METHOD - A metal fiber based on one or several elements from the group of platinum, palladium, rhodium, ruthenium, and iridium with 0 to 30% by weight of one or several additional alloy elements from the group of nickel, cobalt, gold, rhenium, molybdenum, and tungsten, contains 1 to 500 ppm by weight of boron or phosphorus. A non-woven material or netting, in particular for the production of nitrogen oxide or for the production of hydrocyanic acid, is made of such fibers. For the production of fibers based on noble metals having up to 30% by weight of additional alloy metals by drawing the fibers from a melt, the melting point of the metal is reduced by at least 400° C., before drawing of the fibers, by additionally alloying with boron or phosphorus, and the boron or the phosphorus is removed again from the fibers. | 2012-10-04 |
20120251431 | METHOD FOR PRODUCING NITRIDE CRYSTAL - A method for producing a nitride crystal, comprising growing a nitride crystal on the surface of a seed crystal put in a reactor while the temperature and the pressure inside the reactor that contains, as put thereinto, a seed crystal having a hexagonal-system crystal structure, a nitrogen-containing solvent, a starting material, and a mineralizing agent containing fluorine and at least one halogen element selected from chlorine, bromine and iodine are so controlled that the solvent therein could be in a supercritical state and/or a subcritical state to thereby grow a nitride crystal on the surface of the seed crystal in the reactor. | 2012-10-04 |
20120251432 | METHODS FOR THE PRODUCTION OF ALIGNED CARBON NANOTUBES AND NANOSTRUCTURED MATERIAL CONTAINING THE SAME - Disclosed herein is a scaled method for producing substantially aligned carbon nanotubes by depositing onto a continuously moving substrate, (1) a catalyst to initiate and maintain the growth of carbon nanotubes, and (2) a carbon-bearing precursor. Products made from the disclosed method, such as monolayers of substantially aligned carbon nanotubes, and methods of using them are also disclosed. | 2012-10-04 |
20120251433 | PROCESS FOR FABRICATING CARBON NANOTUBES AND APPARATUS FOR IMPLEMENTING THE PROCESS - An industrial process and an apparatus for fabricating carbon nanotubes (CNTs) is provided, comprising synthesis of the carbon nanotubes by decomposing a carbon source brought into contact, in a fluidized-bed reactor, whereby the carbon nanotubes synthesized in the reactor and fixed onto the grains of catalytic substrate in the form of an entangled three-dimensional network, forming agglomerates constituting the CNT powder, are recovered sequentially by discharging them while hot, that is to say at the reaction temperature for synthesizing the CNTs, at the foot of the reactor, the sequence in which the discharges are carried out corresponding to the frequency of filling of the reactor. | 2012-10-04 |
20120251434 | METHOD AND REACTOR FOR TREATING BULK MATERIAL CONTAINING CARBON - The invention relates to a method for treating bulk material which contains carbon and impurities. According to the invention, bulk material is directly heated inductively inside a reactor. | 2012-10-04 |
20120251435 | PROCESS FOR PREPARING ISOCYANATES - A process is proposed for preparing isocyanates by phosgenating the corresponding amines in the gas phase, which comprises
| 2012-10-04 |
20120251436 | Process of conversion of hydrogen sulfide into elemental sulfur on solid oxide catalysts - To minimize the inhibitory effect of sulfur on the oxidation of hydrogen sulfide with oxygen in a gas stream on the solid catalysts, first, the elemental sulfur content in the gas stream is reduced to less than 3.0 mg/l, preferably 0.3 mg/l, and second, the temperature in the oxidation reactor is maintained so that the relative vapor pressure of sulfur in it remains less than 0.25, preferably less than 0.1. The removal of sulfur from the gas stream by washing it with water or aqueous solution decreases the ignition temperature of the process to 155-160° C. Because of this the initial concentration of H | 2012-10-04 |
20120251437 | MAGNETITE IN NANOPARTICULATE FORM - The present invention relates to a process for the polyol-type synthesis of nanoparticulate magnetite starting from mixtures of Fe | 2012-10-04 |
20120251438 | Metal-Organic Frameworks Based on On 2,5-Furandicarboxylic Acid Or 2,5-Thiophenedicarboxylic Acid - The present invention relates to porous metallic frameworks comprising at least one at least bidentate organic compound coordinated to at least one metal ion, wherein the at least one at least bidentate organic compound is derived from 2,5-furandicarboxylic acid or 2,5-thiophenedicarboxylic acid. The present invention further relates to shaped bodies comprising these frameworks, processes for producing them and their use, in particular for the storage and separation of gases. | 2012-10-04 |
20120251439 | Antigens Associated with Inflammatory Bowel Disease Including Ulcerative Colitis - Specific binding members that bind the ED-A isoform of fibronectin for use in methods of diagnosis, detection, imaging and/or treatment of inflammatory bowel disease such as ulcerative colitis and/or for use in delivery to the neovasculature of intestinal tissue of a molecule conjugated to the specific binding member. Specific binding members that bind tenascin-C, especially the A1, A2, A3, A4 and/or D domain tenascin-C large isoform, for use in methods of diagnosis, detection, imaging and/or treatment of ulcerative colitis and/or for use in delivery to the neovasculature of inflammatory bowel disease tissue of a molecule conjugated to the specific binding member. | 2012-10-04 |
20120251440 | METHODS OF MYOCARDIAL PERFUSION IMAGING - The present invention provides a method for identifying and using partial adenosine A | 2012-10-04 |
20120251441 | ADJUVANT IMMUNOTHERAPY FOR THE PREVENTIVE, CURATIVE OR PALLIATIVE TREATMENT OF CHRONIC SYSTEMIC DISEASES SUCH AS CANCER, OF CLINICAL MANIFESTATIONS ASSOCIATED WITH DISEASES LIKE CACHEXIA AND CORRECTION OF ADVERSE EFFECTS OF DRUGS SUCH AS IMMUNOSUPPRESSION, NEUTROPENIA AND LYMPHOPENIA, COMPRISING THE ASSOCIATION OR COMBINATION OF A BIOLOGICAL RESPONSE MODIFIER SPECIALLY SELECTED AND OTHER SUBSTANCES WITH ANTINEOPLASTIC ACTION AND/OR OTHER TREATMENTS - The present invention comprises a new combination or association of pharmacologically active substances and/or non-drug treatments for chronic systemic diseases such as cancer. According to the present invention, the combination or association of substances and/or non-drug treatments is used to treat cancer, clinical problems associated to cancer and adverse side effects related to substances and/or treatments used to fight this illness. The components of the combination or association of substances, the biological response modifier (proteic aggregate of ammonium and magnesium phospholinoleate-palmitoleate anhydride) and at least one substance and/or treatment with antineoplastic properties can be jointly or simultaneously or consecutively or sequentially administered in an appropriate form, according to their chemical properties, and with the use of the most suitable procedures, and also in the most therapeutically effective dose and use. | 2012-10-04 |
20120251442 | Methods for Treatment of Tumors by Direct Administration of a Radioisotope - This invention provides a safer and more effective treatment for non-intracavitary undesirable tissue masses, especially bone cancer and soft tissue tumors. The method involves the direct administration of a therapeutically-effective dose of a formulated radioisotope composition nearby or directly into the tissue mass. Small volumes of the composition are used. | 2012-10-04 |
20120251443 | IMPLANTABLE CONTRAST AGENTS AND METHODS - The present disclosure provides compositions and methods based on implantable contrast agents that are useful for imaging tissue and organs. | 2012-10-04 |
20120251444 | TREATMENT OF LIVER DISORDERS BY ADMINISTRATION OF RAP CONJUGATES - The present invention relates to the use of receptor-associate protein (RAP) and fragments and variants thereof to improve delivery of therapeutic compounds to the liver and provides methods to treat liver disorders and conditions, such as hepatic carcinoma, by administering RAP or RAP variants conjugated to active agents. | 2012-10-04 |
20120251445 | PEPTIDES WHOSE UPTAKE BY CELLS IS CONTROLLABLE - A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. Cleavage of X allows separation of A from B, unmasking the normal ability of the basic amino acids in B to drag cargo C into cells near the cleavage event. X is cleaved extracellularly, preferably under physiological conditions. D-amino acids are preferred for the A and B portions, to minimize immunogenicity and nonspecific cleavage by background peptidases or proteases. | 2012-10-04 |
20120251446 | Peptide Conjugates Comprising Polyhistidine Sequence and Free Cysteine and Their Uses in Imaging - Bioconjugates for use in imaging are disclosed include a linker sequence fused to a polypeptide capable of binding a target in a biological system. The linker sequence is designed so that it is capable of being radiolabelled, e.g. with a complex comprising a radionuclide, via a free cysteine residue and the polyhistidine sequence in the label that are both capable of simultaneously binding to a complex comprising the radionuclide. These interactions can improve significantly the rate and efficiency of radiolabelling compared to either protein with the His-tag or the free cysteine alone. Optionally, the free cysteine residue provides a site which can be covalently bonded to a moiety such as a second label, in a site-specific manner. | 2012-10-04 |
20120251447 | RADIOIODINATED TROPANE DERIVATIVES - The present invention provides novel radio iodinated tropanes incorporating triazole or isoxazole rings. Also provided are methods of preparation of said tropanes from functionalised tropane precursors, using click cycloaddition chemistry, as well as radiopharmaceutical compositions comprising such radio iodinated tropanes. The invention also provides in vivo imaging methods using the radio iodinated tropanes. | 2012-10-04 |
20120251448 | Compounds for Use in the Detection of Neurodegenerative Diseases - Provided are the use of the disclosed compounds as imaging agents and methods for in vivo imaging and detection of pathological characteristics unique to synuclein diseases, such as Parkinson's disease. | 2012-10-04 |
20120251449 | ALDH: A COMPOUND FOR CANCER STEM CELL IMAGING - The present invention claims fluoro- & iodo-containing aldehydes as ALDH substrates for use as diagnostic imaging agents or as therapeutic agents. The aldehydes are both directly and indirectly attached to an aromatic or a straight chain ring. ALDH activity was monitored either by the formation of acid-product or consumption of aldehyde substrates. | 2012-10-04 |
20120251450 | NANOPARTICLES THAT PREFERENTIALLY ASSOCIATE WITH AND KILL DISEASED CELLS FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS - Of the many compositions and methods provided herein, one composition includes a nanoparticle having a first oxide of a first metal and a dopant that includes an ion or an atom of a second metal. A method includes a method comprising providing a plurality of nanoparticles comprising a first oxide of a first metal and a dopant that comprises an ion or an atom of a second metal; providing a diseased cell and a healthy cell; contacting the diseased cell and the healthy cell with the nanoparticle; and allowing the nanoparticle to preferentially associate with the diseased cell. | 2012-10-04 |
20120251451 | Renal Cell Carcinoma Biomarkers - The invention provides markers for renal cancer, polynucleotides encoding same, and precursors thereof. The invention also provides methods for detecting, diagnosing, screening for, monitoring, assessing, and treating renal cancers and related disease conditions in a subject. The invention further provides a method of selecting for or assessing efficacy of agents against renal cancer, and a method for assessing renal cancer cell carcinogenic potential of a compound. The invention further provides localization and imaging methods for renal cancers. Also provided are diagnostic compositions and kits for carrying out methods of the invention. In addition, the invention provides therapeutic applications for renal cancers which employ protein renal cancer markers and polynucleotides encoding same, miRNA renal cancer markers and precursors thereof, and binding agents for the markers. | 2012-10-04 |
20120251452 | APPARATUS AND METHOD FOR IDENTIFYING ONE OR MORE AMYLOID BETA PLAQUES IN A PLURALITY OF DISCRETE OCT RETINAL LAYERS - The present invention is an apparatus to produce an OCT of an eye or a brain of a patient to identify one or more plaques in a plurality of discrete OCT retinal layers. The present invention also includes a plurality of methods for identifying one or more plaques in a plurality of discrete OCT retinal layers that can include a contrast agent and a normative database. | 2012-10-04 |
20120251453 | Methods and Compositions Related to Annexin 1-Binding Compounds - Disclosed are conjugates comprising the annexin 1-binding peptide IFLLWQR covalently linked to a therapeutic or detectable agent. Also disclosed are compositions comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are isolated nucleic acids comprising a nucleic acid sequence encoding a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods comprising administering to a subject a composition comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods of targeting a tumor cell in a subject comprising administering to the subject a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods of targeting a tumor cell in a subject comprising administering to the subject a composition comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. The disclosed targeting is useful for treatment of, for example, cancer. | 2012-10-04 |
20120251454 | Human Anti-IL-23 Antibodies, Compositions, Methods and Uses - A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. | 2012-10-04 |
20120251455 | Hair Growth-Inhibiting Agent - A hair removing agent or a hair growth inhibiting agent is provided by determining an endogenous factor having a hair growth inhibitory activity, screening for substances having an activity similar to that of the endogenous factor or substances enhancing the activity or expression of the endogenous factor, and utilizing the physiological activities of such substances. It has been found that FGF18 inhibits hair growth. A method of screening for FGF18-like active substances, substances that promote the activity of FGF18 or substances that promote the expression of FGF18 to thereby obtain candidates for the hair growth inhibiting agent or hair removing agent is disclosed. Also disclosed is a hair growth inhibiting agent or a hair removing agent comprising, as an active ingredient, FGF18 and/or an FGF18 partial peptide, or an FGF18-like active substance and/or a substance that promotes the activity or expression of FGF18 (e.g., Digenea simplex extract). | 2012-10-04 |
20120251456 | Method for Assessing Skin Condition - A method for evaluating the efficacy of a skin-cleansing composition comprises measuring an ATP level on a skin site after cleansing. A method for evaluating the condition of living skin comprises measuring an ATP level on a skin site. The ATP level may be monitored over time to determine a rate of change in the ATP level on the skin site. | 2012-10-04 |
20120251457 | METHODS AND COMPOSITIONS FOR MODULATING ADIPOCYTE FUNCTION - Methods and compositions for treating obesity and related disorders. The methods include the use of BMP-2, -4, -6 and -7. | 2012-10-04 |
20120251458 | Dyes for Membranes and Biological Structures - The present invention relates to the use of one or more natural dyes, alone or in combination with other dyes for preparation of a composition to stain membranes and biological structures, in order to facilitate their identification during surgical procedures. The present invention relates to the use of one or more natural dyes, alone or in combination with other dyes, to stain membranes and biological structures, in order to facilitate their identification during surgical procedures. | 2012-10-04 |
20120251459 | SPECIFIC INHIBITORS AND ACTIVE SITE PROBES FOR LEGUMAIN - Compounds which specifically inhibit legumain, also known as asparaginyl endopeptidase are provided. The compounds have an epoxide or N-Michael acceptor warhead, and have an asparagine side chain attached to a nitrogen atom in the backbone adjacent the warhead. The compounds also preferably comprise a proline residue adjacent the asparagine, and the compound may also contain a third residue and/or a label for cellular or in vivo imaging of active legumain. | 2012-10-04 |
20120251460 | USE OF VANILLIN DERIVATIVES AS A PRESERVATIVE, PRESERVATION METHOD, COMPOUNDS, AND COMPOSITION - The present invention relates to the use, in a cosmetic, dermatological or pharmaceutical composition, of at least one compound of formula (I): | 2012-10-04 |
20120251461 | [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy - The present invention pertains generally to the field of coolants and medical therapy. More particularly, the present invention relates to certain anti-nociceptive agents, such as [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester, that are potent and long-acting and selectively cooling for non-keratinized epithelial tissues as compared to keratinized epithelial tissues, and are useful, for example, for the treatment of (e.g., the alleviation of symptoms of; the amelioration of) sensory discomfort of non-keratinized stratified epithelial (NKSE) tissue; and so for treatment of: sensory discomfort of an ocular surface, an eyelid, a margin of an eyelid, an anterior part of an eyeball, a conjunctiva, a lachrymal system, a pre-corneal film, or a cornea, a lining of the oral cavity, an internal portion of the lips, a pharyngeal surface, an esophageal surface, or an anogenital surface; eye discomfort, e.g., caused by extended wear of contact lenses, by eye strain and/or fatigue, by air pollutants, by excessive exposure to the sun, by conjunctivitis, by dry eye syndrome; sensory discomfort associated with oral mucositis; airway (e.g., larynx, trachea, and/or bronchi) tightness, discomfort in the airways (e.g., larynx, trachea, and/or bronchi), choking, cough, and/or dyspnea, e.g., associated with asthma and/or chronic obstructive pulmonary diseases (COPD). | 2012-10-04 |
20120251462 | Agent For Smoker Dehabituation - The present invention relates to rosmarinic acid for use in a method for smoker dehabituation, wherein the rosmarinic acid is preferably in the form of a dried, aqueous extract of leaves of lemon balm (Melissa officinalis). In addition, the present invention relates to foods and food supplements for use in a method for smoker dehabituation, wherein these foods and food supplements contain rosmarinic acid, in particular rosmarinic acid in the form of a dried, aqueous extract of leaves of lemon balm (Melissa officinalis). | 2012-10-04 |
20120251463 | Nicotinamide Riboside Kinase Compositions and Methods for Using the Same - The present invention relates to isolated nicotinamide riboside kinase (Nrk) nucleic acid sequences, vectors and cultured cells containing the same, and Nrk polypeptides encoded thereby. Methods for identifying individuals or tumors susceptible to nicotinamide riboside-related prodrug treatment and methods for treating cancer by administering an Nrk nucleic acid sequence or polypeptide in combination with a nicotinamide riboside-related prodrug are also provided. The present invention further provides screening methods for isolating a nicotinamide riboside-related prodrug and identifying a natural source of nicotinamide riboside. | 2012-10-04 |
20120251464 | CHALCONES AS ENHANCER OF ANTIMICROBIAL AGENTS - Compounds are described that are effective in enhancing the efficacy of antimicrobial agents. Also described are methods of using such compounds and compositions that include such compounds. The composition includes a chalcone compound and, optionally, an antimicrobial agent. | 2012-10-04 |
20120251465 | FLAVOR COMPOSITION CONTAINING FLAVONE GLYCOSIDES - The present invention has discovered that flavone glycosides represented by Formula I set forth below have unexpected and advantageous flavor enhancement and modification properties: | 2012-10-04 |
20120251466 | ANTI-EROSION TOOTHPASTE COMPOSITION - Disclosed herein are oral care compositions comprising a fluoride ion source and phosphate salts, and methods of making and using the same. | 2012-10-04 |
20120251467 | FULVIC ACID COMPOSITIONS AND THEIR USE - Carbohydrate-derived fulvic acid (CHD-FA), a salt, ester or derivative thereof for use in the prevention, treatment or inhibition of infection by oral pathogens in a mammal, compositions, particularly compositions suitable for oral administration, comprising the same. | 2012-10-04 |
20120251468 | Compositions Comprising Alginates with High Guluronic Acid/Mannuronic Acid Ratio for use in the Treatment of Dentine Hypersensitivity - The present invention relates to oral care compositions comprising certain alginates for the treatment of dentine hypersensitivity and to their use. | 2012-10-04 |
20120251469 | SUNLESS TANNING WITH PYRANONES AND FURANONES - A composition and method for imparting a sunless tan to skin is described. The composition and method make use of a sunless tanning agent like dihydroxyacetone in combination with an adjuvant which is a pyranone, furanone or a mixture thereof. | 2012-10-04 |
20120251470 | METHOD FOR EXTRACTING A TRADITIONAL HERBAL MEDICINE COMPONENT USING A POLISHED-RICE STEAMING METHOD - Disclosed are: a method for extracting a traditional herbal medicine component comprising a process in which a traditional oriental medicine component is steamed together with polished rice; and a composition for an external application to skin comprising an extract which has been extracted by means of the method. The component extracted by means of the extraction method reduces the cytotoxicity of the traditional oriental medicine, is recognized as being effective in alleviating skin irritation, and exhibits an outstanding skin-whitening effect. | 2012-10-04 |
20120251471 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME - The present invention provides kits and methods for treating hair on the scalp comprising non-toxic compositions providing beneficial effects on hair without employing high temperatures, free radical initiators or rinsing hair after applying the compositions. | 2012-10-04 |
20120251472 | Hair Styling Cosmetic Composition - To provide a hair styling cosmetic composition which is excellent in hair styling property and hair restyling property, even though being water-based and having a low viscosity, and is excellent in non-stickiness, smoothness, and light finish of the hair. A hair styling cosmetic composition comprising (a) (a | 2012-10-04 |
20120251473 | NON-WEIGHING HAIR PREPARATIONS - An agent for treating keratin-comprising fibers, in particular human hair, which includes in a cosmetic carrier at least one cyclic siloxane, at least one C8 to C30 alkyl PEG/PPG dimethicone, and at least one cationic protein hydrolysate. | 2012-10-04 |
20120251474 | COMB POLYMERS FOR THE HAIR - Utilisation of (meth)acrylic comb copolymers with side chains of the hydroxy and alkoxy polyalkylene glycol type in which are present both ethylene oxide and propylene oxide links. These copolymers give a styling effect and an elimination of rinsing. The invention also relates to a cosmetic formulation containing such structures as well as a hair treatment process based on this formulation. | 2012-10-04 |
20120251475 | WATER SOLUBLE POLYMER COMPLEXES WITH SURFACTANTS - A complex including a polymer and a surfactant formed by polymerizing a monomer mixture containing:
| 2012-10-04 |
20120251476 | CLEANSING COMPOSITION - The present invention is related to an aqueous cleansing composition for keratin fibres, especially human hair, comprising at least one amino acid surfactant, and a cationic polymer. Accordingly, the object of the present invention is an aqueous cleansing composition comprising at least one amino acid surfactant of the following structure wherein R | 2012-10-04 |
20120251477 | Gel Carrier for Releasing Active Ingredients - A gel carrier for releasing active ingredients is formed from a co-polymer blend and an active ingredient blend. The co-polymer blend and active ingredient blend are combined and allowed to cool to a desired temperature. When the gel carrier floats in, is immersed, or is exposed to water-based materials, active ingredients are leached out of the gel carrier. | 2012-10-04 |
20120251478 | Method for treatment of a glomerular disease comprising administration of anion exchange resin - Provided is a novel prophylactic and/or therapeutic agent for glomerular disease wherein a pharmaceutically acceptable anion exchange resin, typified by colestimide, is an active ingredient thereof. | 2012-10-04 |
20120251479 | Reduced-Odor Polyol Composition And Method Of Producing Same - A reduced-odor polyol composition for gastrointestinal lavage of a mammal comprises a polyol and at least one acid salt formed from a reaction between a basic catalyst and citric acid. The reduced-odor polyol composition is produced by providing at least one alkylene oxide; providing at least one initiator; reacting the at least one alkylene oxide with the at least one initiator in the presence of a basic catalyst to produce a polyol; and neutralizing the basic catalyst with citric acid, thereby forming at least one acid salt and producing the reduced-odor polyol composition. | 2012-10-04 |
20120251480 | Oil-In-Water External Skin Preparation - The present invention provides an oil-in-water external skin preparation having thread-forming property and an excellent time-dependent stability of the thread-forming property, penetrating well into skin, providing richness and no stickiness when the applied preparation gets dry. The oil-in-water external skin preparation includes (a) 0.01 to 3.0% by mass of polyacrylic acid or metal salt thereof, (b) 0.01 to 1.0% by mass of alkyl-modified carboxyvinyl polymer, (c) 1.0 to 10.0% by mass of polyethylene glycol having an average molecular weight of 1000 or more to 50000 or less of, and (d) 0.5 to 20.0% by mass of oil. | 2012-10-04 |
20120251481 | EMULSIFIED COSMETIC COMPOSITION - An object is to provide an emulsified cosmetic composition which can impart satisfactory taut feeling and yet is free of stickiness, by incorporating polyvinyl alcohol into a soap-based emulsified cosmetic composition. The present invention relates to an emulsified cosmetic composition comprising: (a) polyvinyl alcohol: 0.01% to 1% by mass; (b) a polyethylene glycol having a molecular weight of 15,000 to 25,000: 0.01% to 5% by mass; (c) a higher fatty acid; and (d) a neutralizing agent. | 2012-10-04 |
20120251482 | USE FOR IMPROVING 5-HT FUNCTION AND ENOS EXPRESSION OF KMUPS AMINE SALTS - The synthesized piperazium salt of KMUPs disclosed in the present invention is characterized by presented pharmaceutics having functions to improve 5-HT function and eNOS expression of KMUPS in lung diseases, such as proliferation, obliteration, pulmonary artery hypertension. The pharmaceutical composition for inhibiting monocrotaline (MCT)-induced proliferation of pulmonary artery includes an effective amount of a complex salt of formula (I): | 2012-10-04 |
20120251483 | Infarction Treatment Compositions and Methods - Provided are methods of treating cardiac infarction by using an injectable material to influence cardiac structure and remodeling after infarction. Also provided are kits that comprise an injectable material to influence cardiac structure. | 2012-10-04 |
20120251484 | COLD PREPARED GEL AND METHOD FOR MAKING SAME - A gel comprising water, pectin having a DE from about 62 to 75, soluble saccharide or sugar alcohol solids present in an amount from about 44 to 60% by weight of the gel, and a pH reducing agent for reducing the pH of the gel from a level from about 2 to 3. A method for making the gel without heating or cooling is also disclosed. | 2012-10-04 |
20120251485 | ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15 - To provide a method of detecting abnormal bone metabolism by using a gene strongly expressed in an osteoclast; a method of screening a compound having a therapeutic and/or preventive effect on abnormal bone metabolism; and a pharmaceutical composition for treating and/or preventing abnormal bone metabolism. Provision of a method of detecting abnormal bone metabolism by using the expression of human Siglec-15 gene as an index; a pharmaceutical composition containing an antibody which specifically recognizes human Siglec-15 and has an activity of inhibiting osteoclast formation; and the like. | 2012-10-04 |
20120251486 | MODIFIED HUMAN TUMOR NECROSIS FACTOR RECEPTOR-1 POLYPEPTIDE OR FRAGMENT THEREOF, AND METHOD FOR PREPARING SAME - The present invention relates to a modified human tumor necrosis factor receptor-1 polypeptide to be coupled to a tumor necrosis factor in vivo or ex vivo, or to a fragment thereof. The modified human tumor necrosis factor receptor-1 polypeptide or the fragment thereof according to the present invention exhibit improved resistance against in vivo protease activity, and thus exhibit improved bioavailability and an improved absorption rate. | 2012-10-04 |
20120251487 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS - Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. | 2012-10-04 |
20120251488 | USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS - Methods for treating patients with cancer and autoimmune disorders using IL-28 and IL-29 molecules. The IL-28 and IL-29 molecules include polypeptides that have homology to the human IL-28 or IL-29 polypeptide sequence and proteins fused to a polypeptide with IL-28 and IL-29 functional activity. The molecules can be used as a monotherapy or in combination with other known cancer and/or autoimmune therapeutics. | 2012-10-04 |
20120251489 | ADULT STEM CELL DERIVED CONDITIONED MEDIUM AND/OR ADULT STEM CELLS FOR USE IN THE THERAPEUTIC TREATMENT OF A TUMOR DISEASE - The invention is in the field of therapeutic treatment of tumours. It has been found that the conditioned medium resulting from culturing an adult stem cell capable of differentiating into a plurality of differentiated cell types in a liquid cell culture medium and/or the adult stem cell from which the conditioned medium is obtainable, exert a remarkable anti-tumour effect. The adult stem cell derived conditioned medium preferred in this therapeutic application is a cell free conditioned medium derived from a human liver stem cell (HLSC). | 2012-10-04 |
20120251490 | Compositions And Methods For Immunotherapy - The present invention provides novel immunotherapeutic compositions and methods useful for treating or preventing microbial infections, weakened immune systems, diseases in which cells have become obligately anerobic and cellular proliferative disorders including cancer. The immunotherapeutics herein use benzaldehyde derivatives, precursors and intermediaries alone or in combination with additional therapeutic agents to stimulate the immune system and inhibit cellular proliferation. The immunotherapeutics of the present invention are particularly useful in the treatment of microbial infections and cellular proliferative disorders which are resistant to traditional methods of treatment such as antibiotics and chemotherapy | 2012-10-04 |
20120251491 | FUSED TRICYCLIC ARYL COMPOUNDS USEFUL FOR THE TREATMENT OF VIRAL DISEASES - The present invention relates to novel Fused Tricyclic Aryl Compounds, compositions comprising at least one Fused Tricyclic Aryl Compound, and methods of using the Fused Tricyclic Aryl Compounds for treating or preventing HCV infection in a patient. | 2012-10-04 |